380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
The seed oil debate hinges on data quality, not ideology. When examining randomized controlled trials on polyunsaturated fats versus saturated fats, the critical confounding variable is trans fats—which were unknowingly included in 1960s-70s studies and are proven to be atherogenic. Once you account
2h 25mKey Takeaway
The seed oil debate hinges on data quality, not ideology. When examining randomized controlled trials on polyunsaturated fats versus saturated fats, the critical confounding variable is trans fats—which were unknowingly included in 1960s-70s studies and are proven to be atherogenic. Once you account for trans fats and omega-3 confounders, the net effect of seed oils on cardiovascular mortality is neutral. The lesson: look for converging lines of evidence across multiple study types, acknowledge your biases upfront, and focus on total lifetime exposure to risk factors rather than short-term interventions.
Episode Overview
Dr. Peter Attia and Dr. Lane Norton discuss the controversial topic of seed oils and cardiovascular health. Originally planned as a debate, this episode instead features Dr. Norton presenting the evidence-based case that seed oils are not uniquely harmful, while Dr. Attia steelmans the opposing viewpoint. The conversation examines four main arguments against seed oils: mortality data from RCTs (Minnesota Coronary Experiment and Sydney Heart Study), LDL oxidation mechanisms, industrial processing concerns, and evolutionary perspectives. A central theme is the importance of understanding confounding variables—particularly trans fats—in older nutrition studies, and the need to evaluate converging lines of evidence rather than cherry-picking individual studies.
Key Insights
Trans Fats Are the Critical Confounder in Seed Oil Studies
The most cited studies showing harm from polyunsaturated fats (Minnesota Coronary Experiment, Sydney Heart Study) used margarine that was 25-40% trans fats. Since trans fats are proven to be atherogenic and have since been banned by the FDA, it's impossible to separate whether observed mortality increases were due to polyunsaturated fats or trans fats. This fundamentally undermines the evidence base against seed oils from these older RCTs.
Cardiovascular Disease Requires Decades to Develop—Short Studies Miss the Signal
Most nutrition RCTs run 1-7 years, but cardiovascular disease develops over decades through cumulative LDL exposure. Comparing this to investing: a 9% vs 8.5% annual return looks similar after 2 years but dramatically different after 40 years. Short-duration studies lack the power to detect meaningful differences in cardiovascular outcomes, especially when participants enter with unknown baseline LDL levels and existing plaque burden.
Personal Beliefs Drive Scientific Interpretation as Much as Funding
Dr. Norton emphasizes that while funding conflicts of interest exist, personal beliefs and biases may be equally or more powerful in shaping how people interpret evidence. He acknowledges his own potential biases (training in a low-carb lab, funding from dairy/beef/egg boards) while emphasizing the importance of being transparent about biases and following the consensus of converging evidence rather than cherry-picking studies that confirm pre-existing beliefs.
Fat Structure Determines Membrane Fluidity and Cardiovascular Risk
The distinction between saturated, monounsaturated, polyunsaturated, and trans fats matters because of how fatty acid tails pack into lipoproteins and cell membranes. Cis double bonds (in natural unsaturated fats) create kinks that increase membrane fluidity, while saturated and trans fats pack tightly, creating rigid membranes. This structural difference affects LDL receptor recognition and particle aggregation—key mechanisms in cardiovascular disease progression.
Reverse Causality Can Confound Cholesterol-Mortality Relationships
In very sick or elderly populations, low cholesterol can indicate wasting diseases and poor health rather than cardiovascular protection. This reverse causality makes it difficult to interpret studies in high-risk populations (like post-MI patients in the Sydney Heart Study) where low cholesterol might be a marker of underlying illness rather than a protective factor.
Notable Quotes
"Everyone has bias. Everyone has personal beliefs they developed and that is just a human characteristic. There's no way to get rid of that."
"I think that personal beliefs are actually just as powerful, if not more powerful. I mean, look at how many people spend hours online arguing over politics that get zero money from arguing about politics."
"The scientific method is perfect it is a perfect method but it is done by people who are not and that is why it is so important to look at the overall consensus of the evidence."
"If anybody has a bias against seed oils, it probably should be me. I came from a lab that was very much in line with the lower carb way of thinking."
"Cardiovascular disease is not something that develops in a couple of years. It develops over the course of decades. For example, what I like to compare it to is investing."
Action Items
-
1
Acknowledge Your Biases Before Evaluating Evidence
Before researching a controversial health topic, write down your current beliefs and potential sources of bias (funding, personal diet, social circles). Being upfront about biases helps you recognize when you might be cherry-picking evidence that confirms what you already believe.
-
2
Look for Converging Lines of Evidence, Not Single Studies
Don't base health decisions on individual studies, especially when they conflict with the broader literature. Instead, examine multiple types of evidence (RCTs, mechanistic studies, observational data, meta-analyses) to see if they point in the same direction. If one study contradicts dozens of others, investigate what makes it different.
-
3
Identify Confounding Variables in Nutrition Research
When evaluating nutrition studies, especially older ones, look for confounding variables like trans fats, omega-3s, baseline health status, and study duration. Ask: 'What else changed besides the variable being tested?' This is particularly important for studies from the 1960s-1980s when trans fats were ubiquitous in processed foods.
-
4
Consider Time Horizons When Evaluating Health Interventions
Recognize that chronic disease develops over decades, so short-term studies (1-7 years) may not capture meaningful differences in outcomes. For cardiovascular health specifically, focus on cumulative lifetime exposure to risk factors like LDL cholesterol rather than short-term changes. Think in terms of decades, not months.